Table 2.
Distribution of HPV Detection Results Among the Studied Groups
| Studied Groups | Number | HPV-16 Positivity in: | HPV-18 Positivity in: | HPV-52 Positivity in Serum N (%) | |||
|---|---|---|---|---|---|---|---|
| Bladder Tissue N (%) | Buffy Coat N (%) | Serum N (%) | Bladder Tissue N (%) | Buffy Coat N (%) | |||
| Group I | 20 | 9 (45.0) | 5 (25.0) | 7 (35.0) | 2 (20.0) | 0 (0.0) | 0 (0.0) |
| Group II | 24 | 2 (8.3) | 3 (12.5) | 3 (8.3) | 1 (4.7) | 1 (4.7) | 3 (12.5) |
| Group III | 16 | 7 (43.8) | 5 (31.3) | 6 (37.5) | 3 (18.8) | 2 (12.5) | 4 (25.0) |
| Total | 60 | 18 (30.0) | 13 (21.7) | 16 (26.7) | 6 (10.0) | 3 (5.0) | 7 (11.7) |
| Group IV | 20 | NA | 0 (0.0) | 0 (0.0) | NA | 0 (0.0) | 0 (0.0) |
HPV = human papillomavirus; NA = not analyzed